Literature DB >> 1080668

Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system.

R B Whitney, J G Levy, A G Smith.   

Abstract

Spleen cells from mice immunized against a methylcholanthrene induced rhabdomyosarcoma inhibited tumour cell colony formation in vitro and prevented tumour development in vivo in an adoptive transfer test. Treatment of the immune spleen cells with anti-mouse immunoglobulin serum or passage through a nylon wool column, both of which reduced the percentage of immunoglobulin bearing cells in the population to less than 3-4%, did not alter their anti-tumour effects. In contrast, treatment of the spleen cells with anti-BAomicron serum abolished their anti-tumour effects both in vitro and in vivo. These results indicate that T cells are the mediators of tumour immunity in this chemically induced tumour system.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080668      PMCID: PMC2009404          DOI: 10.1038/bjc.1975.20

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  The immune response and the homograft reaction.

Authors:  H J WINN
Journal:  Natl Cancer Inst Monogr       Date:  1960-03

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.

Authors:  B T Rouse; M Röllinghoff; N L Warner
Journal:  Eur J Immunol       Date:  1973-04       Impact factor: 5.532

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

6.  Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.

Authors:  J M Zarling; S S Tevethia
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

7.  In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.

Authors:  L R Freedman; J C Cerottini; K T Brunner
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

8.  In vitro cytotoxic activity of thymus cells sensitized to alloantigens.

Authors:  J C Cerottini; A A Nordin; K T Brunner
Journal:  Nature       Date:  1970-07-04       Impact factor: 49.962

9.  Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis.

Authors:  J C Leclerc; E Gomard; F Plata; J P Levy
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

10.  In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.

Authors:  E W Lamon; H M Skurzak; E Klein; H Wigzell
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  2 in total

1.  The immune response to oxidized ferredoxin. II. Cross reactivity of cells and antisera to modified ferredoxins and the nature of the cells responding in vitro.

Authors:  D S Gregerson; B Kelly; J G Levy
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

2.  In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.

Authors:  R C Burton; N L Warner
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.